OBJECTIVE
To evaluate the efficacy of intermittent percutaneous posterior tibial nerve stimulation (PPTNS) in patients with refractory interstitial cystitis.
PATIENTS AND METHODS
One man and 13 women (mean age 58.3 years) with suprapubic or perineal pain were enrolled in a prospective open study, in which they had 10 weekly sessions of PPTNS. Their mean duration of symptoms was 8.3 years. All patients were previously diagnosed as having interstitial cystitis according to the National Institute of Diabetes and Digestive and Kidney Diseases criteria. The response to the treatment were assessed using voiding diary, visual analogue scale diary for a pain index, and the Interstitial Cystitis Problem Index (ICPI), O’Leary/Sant Interstitial Cystitis Symptom Index (ICSI) and the 36‐item short‐form health survey (SF‐36) quality‐of‐life questionnaire.
RESULTS
Of the 14 patients, 13 completed the 10 weeks of treatment with no complications; 12 continued treatment for a short period after the study. There were no statistically significant changes in pain scores, voiding frequency and volumes, or in the ICPI, ICSI and SF‐36 scores. However, there was an improvement in some patients, with one having complete resolution of the pain.
CONCLUSION
Intermittent PPTNS in patients with refractory interstitial cystitis has no significant clinical effect over 10 weeks of treatment.
In the treatment of subungual glomus tumors, the nail bed margin approach is a simple, feasible, effective new method with a low complication and recurrence rate. It can sufficiently expose and completely excise tumors at any subungual region. This approach is expected to be an excellent alternative approach for the excision of subungual glomus tumors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.